Health
J&J vaccine adds to COVID-19 armoury, includes South African variant – Reuters
Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving…
(Reuters) – Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving health officials another weapon to tackle the pandemic.
In the trial of nearly 44,000 volunteers, the level of protection against moderate and severe COVID-19 varied from 72% in the United States, to 66% in Latin America and just 57% in South Africa, from where a worrying variant has spread.
The data showed that the vaccines…
-
Noosa News24 hours agoQueensland dancer Zai Calliste makes it to English National Ballet
-
Noosa News22 hours agoGWS Giants vs Hawthorn Hawks live: AFL elimination finals scores and stats, Fremantle take on Gold Coast, league admits Cam Rayner error
-
General21 hours agoNRL live: Dragons vs Panthers, Titans vs Tigers, Bulldogs vs Sharks
-
General17 hours agoVideo allegedly showing man trying to catch freshwater crocodile prompts investigation